„Most life sciences companies face similar challenges as they grow: first and foremost, the R&D and production infrastructure meeting GMP and GLP standards. In recent years, “CMB medicina” together with partners, have been carrying out R&D and production activities in the field of health technologies and biotechnologies quite intensively, therefore the need for infrastructure capacity has increased, and the possibility of concentrating activities in one place in Vilnius seemed appropriate. Therefore, in order to make better use of networking and synergy opportunities for faster development of “CMB medicina” and other companies in the sector, we chose VCIIP.”

„We have never had any doubts about the development of “CMB medicina” in Vilnius. And the choice to plan the development at VCIIP was determined by several important factors: first of all – the developed transport infrastructure and possibility to establish relatively quickly, as well as the strong core of biotechnology companies already established at VCIIP and the neighbourhood of Vilnius University and Vilnius Tech. These are important conditions that, with the development of the company’s R&D and production infrastructure, will enable the growth of both the company and the cluster of advanced therapy medicinal products and other health technologies and biotechnologies research coordinated by “CMB medicina”.”

„To continue offering Lithuanian and foreign families a world-class education with the infrastructure that meets its needs, we have planned the development of our new campus in Vilnius City Innovation Industrial Park. We have chosen VCIIP not only because of its special location surrounded by nature, but also because of the strong scientific and business community that is emerging in the innovation industrial park, with which we expect strong synergies. We employ the latest technology to enhance children’s learning experience and therefore this is an extraordinary opportunity to integrate experiential education into the learning process and to give students a chance to observe closely how scientific discoveries and innovations are born.”

„The Stem Cell Research Centre has reached the point for development. We chose a place for it in Vilnius, because the largest biotechnology competencies in Lithuania are concentrated here. For us, Vilnius is a strategic place for development due to employees, logistics and interaction with other companies in our group. We chose Vilnius City Innovation Industrial Park because of the convenient territory for business development and important communications. In addition, a unique concentration of life sciences companies and research institutions is forming in this area, with which we expect high synergy. This will be a great place to work for our existing and new employees. We have already envisaged opportunities for further development of the company – we have left room for the second stage of the company’s development. When the company will need larger biotechnology production facilities, we hope to establish a 15,000 m2 biotechnology plant here in the future.”

„The ability to establish and adapt infrastructure to our needs comes rarely, especially in such a convenient location. We see the proximity of creative companies and research institutions in the park as an opportunity to strengthen business-business and science-business synergies, which will help to implement complex projects more efficiently. No less important reason – we believe in Vilnius as a city where the highest-level professionals would like to live and create, we believe in the vision and mission of the Park. Therefore, the decision to settle at VCIIP was very simple.”

“Our decision to settle at VCIIP is based on several reasons – it is a convenient location with developed infrastructure, rapidly growing VCIIP life sciences community, and of course – the value proposition itself, which allows us to plan the rapid development of the company. In preparation for the expansion of the production of immunological diagnostic tests and their components, we are going to set up a factory and laboratory to develop new products at VCIIP by the end of 2023. It’s an important move which will help us to grow the company’s scientific and innovative potential in the future.”

“The VCIIP management team is highly oriented to life sciences sector growth and has put significant effort into accommodating our requirements and helping us grow.”

„Our main goal is to expand our business in the high-tech field, which requires highly qualified professionals and large-scale research as well as collaboration with research institutions or private companies in the biotechnology sector. Therefore, the opportunity to set up in Vilnius City Innovation Industrial Park proved to be attractive not only because of its convenient location and well-developed infrastructure, but also because of the strong life sciences companies that are developing there.”

“We have chosen VCIIP because of its amazing location — it gave us the opportunity to develop next to innovative modern companies, thus improving positions by attracting potential investors and commercial partners. Plus, nearby is Vilnius Gediminas Technical University.”

“The opportunity to settle down in the Vilnius City Innovation Industrial Park seemed attractive due to the existing infrastructure, as well as great VCIIP strategy to create an ecosystem of innovations and good financial value. Continuing smooth and expeditious communication with the operator, its flexibility in dealing with various issues and finding the best solution has helped to make a definite investment in the park.”